By Business/Source
Currency:USD
2025/FY
Stock NameRevenueRatio
Minimal Residual Disease (MRD)212.33M76.66%
Immune Medicine64.64M23.34%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
United States276.98M100.00%